KINDRED HEALTHCARE, INC Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheet

In millions of USD, except per-share amounts

	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q3 FY2013 As of Sep 30, 2013	Q2 FY2013 As of Jun 30, 2013
ASSETS
Current assets:
Cash and cash equivalents
Cash–restricted
Insurance subsidiary investments
Accounts receivable less allowance for loss of $67,227 ─ March 31, 2018 and $96,899 ─ December 31, 2017
Inventories
Deferred tax assets
Income taxes
Interest deposit on senior unsecured notes held in escrow
Assets held for sale
Other (Note 13)
Current assets

Land
Buildings
Equipment
Construction in progress
Property and equipment
Accumulated depreciation
Property and equipment, net
Goodwill
Intangible assets less accumulated amortization of $64,836 ─ March 31, 2018 and $77,603 ─ December 31, 2017
Assets held for sale
Insurance subsidiary investments
Deferred tax assets
Proceeds from senior unsecured notes held in escrow
Acquisition deposit
Other (Note 13)
Total assets

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
Salaries, wages and other compensation
Due to third party payors
Professional liability risks
Accrued lease termination fees
Other accrued liabilities (Note 13)
Long-term debt due within one year
Current liabilities
Long-term debt – senior unsecured notes due 2020 and 2023
Long-term debt – other
Long-term debt
Professional liability risks
Deferred credits and other liabilities
Deferred tax liabilities
Deferred credits and other liabilities (Note 13)
Equity:
Stockholders' equity:
Common stock, $0.25 par value; authorized 175,000 shares; issued 91,279 shares ─ March 31, 2018 and 91,454 shares ─ December 31, 2017
Capital in excess of par value
Accumulated other comprehensive income
Accumulated deficit
Stockholders' equity
Noncontrolling interests
Total equity
Total liabilities and equity

Comments